Early decrease in resting energy expenditure with bedtime insulin therapy

Diabetes Metab. 2009 Sep;35(4):332-5. doi: 10.1016/j.diabet.2009.04.003. Epub 2009 Jul 8.

Abstract

Aims: In type 2 diabetes (T2D), insulin-induced weight gain may stem from a reduction in resting energy expenditure (REE). We sought to determine the early effects of insulin introduction on REE in 20 poorly controlled T2D patients.

Methods: After improving the glycaemia, REE was measured on Day 0 and Day 4 during two treatment regimens: bedtime insulin (n=10, group 1); and one off (3-day) intravenous insulin infusion (n=10, group 2).

Results: Both groups were similar in age, gender, BMI, C-peptide, HbA(1c) and initial REE. By Day 4, fasting glycaemia had similarly improved in both groups: group 1: -5.3+/-2.7mmol/L vs group 2: -5.8+/-4.2 mmol/L. In group 2, the second REE was measured 12h after stopping the intravenous insulin infusion, whereas subcutaneous insulin was maintained in group 1. REE did not change in group 2 (-1.3+/-6.5%), whereas it decreased significantly in group 1 (-8.0+/-7.0%; P<0.05).

Conclusion: Bedtime insulin led to an early and specific reduction in REE.

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Blood Glucose / analysis
  • Body Mass Index
  • C-Peptide / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Energy Metabolism / physiology*
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Infusions, Intravenous
  • Injections, Subcutaneous
  • Insulin / administration & dosage*
  • Insulin / analogs & derivatives
  • Insulin / therapeutic use
  • Male
  • Middle Aged
  • Respiration
  • Rest
  • Statistics, Nonparametric
  • Time Factors
  • Weight Gain / drug effects

Substances

  • Blood Glucose
  • C-Peptide
  • Glycated Hemoglobin A
  • Insulin